As of April 2024 Athersys has a market cap of $0.83 Million. This makes Athersys the world's 8351th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.83 M | -32.5% |
2023 | $1.23 M | -91.46% |
2022 | $14.45 M | -93.19% |
2021 | $0.21 B | -39.93% |
2020 | $0.35 B | 79.83% |
2019 | $0.19 B | -5.41% |
2018 | $0.20 B | -3.15% |
2017 | $0.21 B | 63.44% |
2016 | $0.13 B | 52.23% |
2015 | $86.23 M | -29.77% |
2014 | $0.12 B | -30.52% |
2013 | $0.17 B | 214.19% |
2012 | $56.24 M | 38.32% |
2011 | $40.66 M | -13.04% |
2010 | $46.75 M | -40.19% |
2009 | $78.17 M | 817.64% |
2008 | $8.51 M | -90.83% |
2007 | $92.93 M |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $351.20 B | 42,150,655.81% | ๐บ๐ธ USA |
Pfizer PFE | $143.77 B | 17,255,224.02% | ๐บ๐ธ USA |
Amgen AMGN | $140.81 B | 16,900,068.86% | ๐บ๐ธ USA |
Sanofi SNY | $113.31 B | 13,599,690.89% | ๐ซ๐ท France |
Merck MRK | $317.21 B | 38,071,215.74% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $97.89 B | 11,748,837.47% | ๐บ๐ธ USA |
Moderna
MRNA | $39.05 B | 4,687,084.09% | ๐บ๐ธ USA |
Arena Pharmaceuticals
ARNA | $6.16 B | 739,854.52% | ๐บ๐ธ USA |